Skip to content
★ Sign in to follow
SG

Susan G. Kim

Chief Financial Officer
Pacific Biosciences of California, Inc.
Total declarations
15
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (10 ops.)
€925k

Latest filing published 02 Oct 2024 for Pacific Biosciences of California, INC., €31k.

Filing timeline

BuySale
Susan G. Kim

Insider track record

Disclosed buys
0
Disclosed sells
10

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Susan G. Kim: trading record in brief

All filings by Susan G. Kim on record concern Pacific Biosciences of California, Inc., in the capacity of finance chief. Between 28 September 2020 and 30 September 2024, the trades on record add up to 15 filings.

Sales make up the whole of the open-market record (10 sales, €925k). The rest of the record consists of 5 share grants. 2024 to date brings no purchases and 4 sales.

The newest entry dates from 2 October 2024: an open-market sale of €31k, in Pacific Biosciences of California, Inc. The median gap between a trade and its publication by SEC (Form 4) is 3 days. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Susan G. Kim

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations11 total

11 of 11 declarations